◼ Archived
Health
🔮 fades ✓
Modular in vivo antibody–ADC click to reverse drug resistance in tumours
5 news sources are covering this Health story right now — Archynetys is tracking how fast it spreads.
Adc
2 trends tracked about this subject — the full history, oldest to newest below.
◼ Archived
Business
🔮 fades ✓
Novartis to Buy Myricx Bio for Up to $1.5 Billion
Novartis is expanding its antibody-drug conjugate (ADC) pipeline through the acquisition of U.K.-based cancer biotech Myricx Bio for up to $1.5 billion.